Iridex share price logo

Iridex

NASDAQ: IRIX

$0.74

-0.02

(-2.79%)

Live

as on

Iridex Stock Performance

as on October 24, 2026 at 6:22 am IST

  • Day's Low

    Day's High

    $0.74
    $0.76
    downward going graph

    0.13%

    Downside

    2.56%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.61
    $1.65
    downward going graph

    18.08%

    Downside

    122.42%

    Upside

    downward going graph

Iridex share price movements today

Previous Close
$0.76
Open
$0.74
Volume
640.1K
Market Cap
$13.5M
Day's Low - High
$0.74 - $0.76
52 Week Low - High
$0.61 - $1.65

Iridex Historical Returns

1 Month Return
+ 20.24 %
3 Month Return
-17.32 %
1 Year Return
-30.06 %
3 Year Return
-74.25 %
5 Year Return
-89.9 %

Iridex Stock Fundamentals & Key Indicators

Check Iridex market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.5M

EPS (TTM)

-0.2034

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.77

Industry PE ratio

-5.10

PEG Ratio

-0.08

EBITDA

-1.7M

Revenue (TTM)

51.6M

Profit Margin

36.23%

Return On Equity TTM

-78.94%

Iridex vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iridex with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Hold$13.5M-89.90%-3.7736.23%0.00%
Buy$121.0B-21.53%22.7566.69%3.07%
Buy$51.0B-22.73%50.8077.98%0.00%
StrongBuy$116.8B11.37%30.5965.17%1.18%
StrongBuy$173.9B-19.11%32.3456.80%2.51%

Stock Returns calculator for Iridex Stock including INR - Dollar returns

The Iridex stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iridex investment value today

Current value as on today

₹73,528

Returns

-₹26,472

(-26.47%)

Returns from Iridex Stock

-₹32,018 (-32.02%)

Dollar Impact

₹5,546 (+5.55%)

Analyst Recommendation on Iridex Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Iridex. Average target price of $2.75

Iridex Share Price Target

Get share price movements and forecasts by analysts on Iridex.

What analysts predicted

73.05%UPSIDE

Target Price

$2.75

Current Price

$0.741

Analyzed by

6 Analysts

Target

$2.75

Iridex target price $2.75, a slight upside of 73.05% compared to current price of $0.741. According to 6 analysts rating.

Indian Investors' Interest in Iridex Stock

Search interest for Iridex Stock has increased by 65% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:65% versus previous 30 day period

Iridex Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
11
12
11
12
11
13
12
14
11
12
Gross Profit
4
5
4
5
5
4
4
5
4
4
Operating Income
-3
-2
-1
0
0
0
-1
0
0
-1
EBITDA
-3
-2
-1
0
-1
0
-1
0
0
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-2
-1
0
-1
0
-1
0
0
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-3
-2
-1
0
-1
0
-1
0
0
-1
Net Profit Margin
37.19%
40.65%
37.33%
44.00%
42.49%
33.92%
32.15%
38.27%
40.18%
34.19%

Iridex Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
41
42
43
36
53
56
51
48
52
Gross Profit
15
17
17
15
22
25
21
19
19
Operating Income
-12
-12
-8
-6
-7
-7
-10
-8
-2
EBITDA
-12
-12
-8
-6
-3
-6
-7
-7
-2
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
1
1
2
1
1
Income Before Tax
-12
-12
-8
-6
-5
-7
-9
-8
-4
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-12
-12
-8
-6
-5
-7
-9
-8
-4
Net Profit Margin
37.27%
41.01%
41.29%
42.80%
42.36%
44.53%
42.04%
40.07%
36.65%

Iridex Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-2
-1
0
-1
0
-1
0
0
-1
Operating Cash Flow
-1
-1
-3
-1
-1
0
-1
0
-1
0
Investing Cash Flow
0
-
0
0
0
0
0
0
0
0
Financing Cash Flow
-
-
2
0
6
0
0
0
0
0
Change in Cash
-1
-1
0
-1
4
0
-1
0
-1
0

Iridex Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-12
-8
-6
-5
-7
-9
-8
-4
Operating Cash Flow
-3
-10
-7
-3
8
-9
-6
-7
-2
Investing Cash Flow
0
0
0
0
-5
0
0
0
0
Financing Cash Flow
2
10
0
2
9
0
0
2
5
Change in Cash
-2
0
-8
-1
12
-9
-6
-4
3

Global Institutional Holdings in Iridex

Check out the Institutions with significant holdings in Iridex.

Funds
Holdings
VANGUARD INDEX FUNDS
2.93%
Vanguard
2.93%
Fidelity Concord Street Trust
0.64%

Insights on Iridex

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 11.79M → 12.56M (in $), with an average increase of 6.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, IRIX stock has moved up by 20.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Medtronic plc has given 30.5% return, outperforming this stock by 104.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 17.7% return, outperforming this stock by 47.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -184.0K → -1.26M (in $), with an average decrease of 163.2% per quarter

About Iridex

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.
OrganisationIridex
Headquarters1212 Terra Bella Avenue, Mountain View, CA, 94043, US
IndustryMedical - Devices
CEOPatrick Mercer

Key Management of Iridex

Name

Title

Mr. Patrick Mercer

CEO, President & Director

Mr. Romeo R. Dizon

Chief Financial Officer

Mr. Bassem BouHabib

SVP of International Sales & Business Development

Ms. Leigh Salvo

Head of Investor Relations

Mr. Scott A. Shuda J.D.

Executive Chairman

FAQs

What is Iridex share price today?

Iridex share price today is $0.74 as on . Iridex share today touched a day high of $0.76 and a low of $0.74.

What is the 52 week high and 52 week low for Iridex share?

Iridex share touched a 52 week high of $1.65 on and a 52 week low of $0.61 on . Iridex stock price today i.e. is trending at $0.74,which is 55.04% down from its 52 week high and 22.08% up from its 52 week low.

What is Iridex's market capitalisation today?

Iridex market capitalisation is $0.00T as on .

How to invest in Iridex Stock (IRIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Iridex on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Iridex Stock (IRIX) from India?

Indian investors can start investing in Iridex (IRIX) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Iridex stock (as per the Rupee-Dollar exchange rate as on ). Based on Iridex share’s latest price of $0.74 as on October 24, 2026 at 12:52 am IST, you will get 13.4953 shares of Iridex. Learn more about fractional shares .

What are the returns that Iridex has given to Indian investors in the last 5 years?

Iridex stock has given -89.9% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?